Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Clinical trial NCT00520767 · COMPLETED
Trial details
- NCT number
- NCT00520767
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-10-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.